ResearcherOkayama UniversityActive in the last 2 years
Shinji Kuroda
Matched on ORCID iD 0000-0002-4484-1253; OpenAlex author ID A5020188029. Sources: OpenAlex.
Their work
- Papers
- 16 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: 2 papers · 2025: 4 papers · 2026: 3 papers
Papers 16
- Turning pancreatic cancer from cold to hot: the promise of a p53-expressing oncolytic adenovirus (OBP-702). Co-author DOI 10.1007/s10147-026-02991-7↗
- Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. Co-author DOI 10.1016/j.omton.2026.201180↗
- p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. Co-author DOI 10.1038/s41417-025-00989-3↗
- Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone. Co-author DOI 10.1007/s00262-025-03946-z↗
- Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1/2 pathway promote chemoresistance in pancreatic cancer. Co-author DOI 10.1038/s41416-025-03192-1↗
- [Development of Oncolytic Virus Immunotherapy to Improve the Immunosuppressive Microenvironment in Pancreatic Cancer]. Co-author PMID 40420372↗
- [Development of Immunotherapy to Target Autophagy‒Dependent Immune Evasion in Pancreatic Cancer]. Co-author PMID 41139971↗
- Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. First author DOI 10.1038/s41416-024-02583-0↗
- Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. First author DOI 10.1038/s41416-024-02850-0↗
- Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer. Co-author DOI 10.1007/s00262-022-03334-x↗
- [Therapeutic Effect of Oncolytic Adenovirus on Pancreatic Cancer Stroma]. Co-author PMID 38035844↗
- Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer. Co-author DOI 10.1016/j.omto.2022.09.003↗
- [Telomerase-Specific Oncolytic Adenovirus Expressing p53 Gene Stimulating CD8+ Memory T Cells in Pancreatic Cancer]. First author PMID 36281608↗
- Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis. Co-author DOI 10.1016/j.canlet.2020.10.015↗
- Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. Co-author DOI 10.1016/j.omto.2020.03.016↗
- The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer. Co-author DOI 10.1186/s13046-018-0981-2↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Toshiyoshi Fujiwara · 16 shared papers, 2018–2026 · strength 2.96
- Paper Turning pancreatic cancer from cold to hot: the promise of a p53-expressing oncolytic adenovirus (OBP-702). DOI 10.1007/s10147-026-02991-7↗
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper [Development of Oncolytic Virus Immunotherapy to Improve the Immunosuppressive Microenvironment in Pancreatic Cancer]. PMID 40420372↗
- Ryuichi Yoshida · 9 shared papers, 2018–2026 · strength 1.40
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Paper Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic aden… DOI 10.1038/s41416-024-02583-0↗
- Yuzo Umeda · 6 shared papers, 2020–2026 · strength 0.99
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Paper Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcit… DOI 10.1007/s00262-022-03334-x↗
- Masashi Hashimoto · 5 shared papers, 2022–2026 · strength 0.94
- Paper Turning pancreatic cancer from cold to hot: the promise of a p53-expressing oncolytic adenovirus (OBP-702). DOI 10.1007/s10147-026-02991-7↗
- Paper Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic aden… DOI 10.1038/s41416-024-02583-0↗
- Paper Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-spec… DOI 10.1038/s41416-024-02850-0↗
- Yasuo Nagai · 4 shared papers, 2023–2026 · strength 0.88
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Paper Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppr… DOI 10.1007/s00262-025-03946-z↗
- Yoshinori Kajiwara · 4 shared papers, 2022–2026 · strength 0.78
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Paper Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcit… DOI 10.1007/s00262-022-03334-x↗
- Ryohei Shoji · 3 shared papers, 2020–2026 · strength 0.58
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016↗
- Kazuya Yasui · 3 shared papers, 2024–2025 · strength 0.54
- Paper Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1/2 pathway promote chemoresistance in pancrea… DOI 10.1038/s41416-025-03192-1↗
- Paper Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic aden… DOI 10.1038/s41416-024-02583-0↗
- Paper Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-spec… DOI 10.1038/s41416-024-02850-0↗
- Takeyoshi Nishiyama · 2 shared papers, 2026 · strength 0.48
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Kanto Suemori · 2 shared papers, 2025 · strength 0.45
- Tomohiko Yagi · 2 shared papers, 2025 · strength 0.42
- Paper Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1/2 pathway promote chemoresistance in pancrea… DOI 10.1038/s41416-025-03192-1↗
- Paper Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppr… DOI 10.1007/s00262-025-03946-z↗
- Shohei Nogi · 2 shared papers, 2025 · strength 0.42
- Paper Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1/2 pathway promote chemoresistance in pancrea… DOI 10.1038/s41416-025-03192-1↗
- Paper Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppr… DOI 10.1007/s00262-025-03946-z↗
- Kosei Takagi · 2 shared papers, 2025 · strength 0.42
- Paper Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1/2 pathway promote chemoresistance in pancrea… DOI 10.1038/s41416-025-03192-1↗
- Paper Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppr… DOI 10.1007/s00262-025-03946-z↗
- Hiroyuki Araki · 2 shared papers, 2020–2022 · strength 0.23
- Paper Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic… DOI 10.1016/j.omto.2022.09.003↗
- Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016↗
- Hiroyoshi Y. Tanaka · 1 shared paper, 2026 · strength 0.23
- Mitsunobu R. Kano · 1 shared paper, 2026 · strength 0.23
- Atsushi Masamune · 1 shared paper, 2026 · strength 0.23
- Yousuke Takahashi · 1 shared paper, 2025 · strength 0.23
- Hiroki Kajioka · 1 shared paper, 2021 · strength 0.12
- Takeshi Koujima · 1 shared paper, 2020 · strength 0.10
- Kazuya Kuwada · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.